Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model

BACKGROUND: DNA methyltransferase inhibitors (DNMTis) improve survival for patients with myelodysplastic syndromes (MDS) and those with acute myeloid leukemia (AML) unable to receive standard cytotoxic chemotherapy and are, accordingly, the backbone of standard-of-care treatment for these conditions...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Target Oncol
Autori principali: Ramsey, Haley E., Oganesian, Aram, Gorska, Agnieszka E., Fuller, Londa, Arrate, Maria, Boyd, Kelli, Keer, Harold, Azab, Mohammad, Savona, Michael R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2020
Soggetti:
Original Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7182630/
https://ncbi.nlm.nih.gov/pubmed/32222953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-020-00709-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi